buserelin has been researched along with Familial Precocious Puberty in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (45.90) | 18.7374 |
1990's | 22 (36.07) | 18.2507 |
2000's | 10 (16.39) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (1.64) | 2.80 |
Authors | Studies |
---|---|
Jian, L; Li, H; Xiang, JB; Zhu, XX | 1 |
Antoniazzi, F; Zamboni, G | 1 |
Albertsson-Wikland, K; Aman, J; Aronson, AS; Gustafsson, J; Häger, A; Ivarson, S; Jonsson, B; Kriström, B; Marcus, C; Nilsson, KO; Proos, LA; Tuvemo, T; Westgren, U; Westphal, O | 1 |
Jonsson, B; Lönnerholm, T; Proos, LA; Tuvemo, T | 1 |
Tanaka, T | 1 |
Sandow, J | 1 |
Waxman, J | 1 |
Costigan, DC; Fazekas, AT; Holland, FJ; Jenner, MR; Luder, AS; Wielgosz, G | 1 |
Brook, CG; Donaldson, MD; Lee, TJ; Price, DA; Savage, DC; Stanhope, R | 1 |
Juul, A; Krabbe, S; Müller, J; Nielsen, CT; Scheike, T; Skakkebaek, NE | 1 |
Antoniazzi, F; Bernasconi, S; Bozzola, M; Cisternino, M; Corrias, A; De Luca, F; De Sanctis, C; Nizzoli, G; Rigon, F; Zamboni, G | 1 |
Bourguignon, JP; Craen, M; Fawe, L; Heinrichs, C; Malvaux, P; Vanderschueren-Lodeweyckx, M | 1 |
Balsamo, A; Bovicelli, L; Brondelli, L; Cacciari, E; Cassio, A; Cicognani, A; Colli, C; Mandini, M; Pirazzoli, P; Tani, G | 1 |
Benso, L; Stasiowska, B; Vannelli, S | 1 |
Drop, SL; Hümmelink, R; Odink, RJ; Oostdijk, W; Partsch, CJ; Sippell, WG | 1 |
Drop, SL; Hümmelink, R; Odink, RJ; Oostdijk, W; Partsch, CJ; Peter, M; Sippell, WG | 1 |
Barnes, KM; Cutler, GB; Hill, S; Jones, J; Manasco, PK; Oerter, KE | 1 |
Berger, H; Dengg, K; Fink, FM; Glatzl, J; Heitger, A; Kreczy, A; Tabarelli, M | 1 |
Flyvbjerg, A; Frystyk, J; Juul, A; Müller, J; Skakkebaek, NE | 1 |
Juul, A; Müller, J; Skakkebaek, NE | 1 |
Baroncelli, GI; Bertelloni, S; Cappa, M; De Sanctis, C; Lala, R; Matarazzo, P; Saggese, G | 1 |
Baroncelli, GI; Bertelloni, S; Perri, G; Saggese, G; Sorrentino, MC | 1 |
Anzo, M; Hasegawa, T; Ishii, T; Matsuo, N; Sasaki, G; Sato, S; Tamai, S | 1 |
Fisker, S; Hertel, T; Juul, A; Müller, J; Orskov, H; Scheike, T; Skakkebaek, NE | 1 |
Spiliotis, BE | 1 |
Baroncelli, GI; Bertelloni, S; Ferdeghini, M; Menchini-Fabris, F; Saggese, G | 1 |
Antoniazzi, F; Arrigo, T; Bertelloni, S; Borrelli, P; Cisternino, M; De Luca, F; Galluzzi, F; Mengarda, F; Osio, D; Pasquino, AM; Tatò, L | 1 |
Andersson, AM; Müller, J; Sehested, A; Skakkebaek, NE | 1 |
Gustafsson, J; Proos, LA; Tuvemo, T | 1 |
Arisaka, O; Nakayama, Y; Tadokoro, R; Tokita, A; Yamashiro, Y | 1 |
Yokoya, S | 1 |
Leung, A; Low, LC; Wang, C; Zhong, CQ | 1 |
Antony, G; Byrne, GC; Cowell, CT; Ennis, G; Gold, H; Howard, N; Quigley, C; Silink, M; Warne, GL; Werther, GA | 1 |
Aubert, ML; Reznik, Y; Sizonenko, PC | 1 |
Brook, CC; Stanhope, R | 1 |
Barg, E; Hirowska, I; Iwanicka, Z; Pellar, J; Wasikowa, R | 1 |
Bassi, F; Serio, M | 1 |
Albanese, A; Becherucci, P; Chiti, G; Galluzzi, F; La Cauza, E; Merello, G; Salti, R | 1 |
Chan, FL; Cheung, PT; Low, LC; Wang, C | 1 |
Azaretzky, M; Boquete, HR; Cagide, AL; Damilano, S; Fideleff, HL; Levalle, O | 1 |
Drop, SL; Ladée-Levy, JV; Pouw, IS; Slijper, FM | 1 |
Brauner, R; Fontoura, M; Rappaport, R | 1 |
Baldini, A; Carani, C; Pacchioni, C; Zini, D | 1 |
Bailey, JD; Fazekas, AT; Fishman, L; Holland, FJ | 1 |
Costigan, DC; Fishman, L; Holland, FJ; Leeder, S; Luna, L | 1 |
Domokos, I; Faredin, I; Iványi, T; Janáky, T; Julesz, J; László, F | 1 |
Brauner, R; Hauschild, MC; Pariente, D; Rappaport, R; Thibaud, E | 1 |
Brauner, R; Rappaport, R | 1 |
Baird, DT; Fraser, HM | 1 |
Bot, A; de Jong, FH; Drop, SL; Gons, M; Meradji, M; Odink, RJ; Otten, BJ; Rouwé, C; Slijper, FM; Van Maarschalkerweerd, MW | 1 |
Aubert, ML; Reznik, Y; Sizonenko, PC; Winiger, BP | 1 |
Sippell, WG | 1 |
Bourguignon, JP; Craen, M; Delire, M; Du Caju, M; Heinrichs, C; Lambrechts, L; Malvaux, P; Van Vliet, G; Vanderschueren-Lodeweyckx, M; Vandeweghe, M | 1 |
Bourguignon, JP; Craen, M; Du Caju, MV; Ernould, C; Malvaux, P; Van Vliet, G; Vanderschueren-Lodeweyckx, M; Vandeweghe, M | 1 |
Blumberg, A; Girard, J; Hadziselimovic, F; Rime, JL; Zumsteg, U; Zurbrügg, RP | 1 |
Hibi, I; Kato, K; Nakazima, H; Suwa, S | 1 |
Glatzl, J; Karpellus, E; Ortner, A; Tabarelli, M | 1 |
Ahuja, MM; Ammini, AC; Jayakumar, B; Karmarkar, MG; Khurana, ML; Kumar, KM; Menon, PS | 1 |
Adams, J; Brook, CG; Stanhope, R | 1 |
McNinch, AW; Savage, DC; Ward, I; Ward, PS | 1 |
Bischof, P; Brauner, R; Rappaport, R; Sizonenko, PC; Thibaud, E | 1 |
7 review(s) available for buserelin and Familial Precocious Puberty
Article | Year |
---|---|
Central precocious puberty: current treatment options.
Topics: Body Height; Buserelin; Child; Diagnosis, Differential; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Male; Puberty, Precocious | 2004 |
[Precocious puberty].
Topics: Biomarkers; Buserelin; Diagnosis, Differential; Diagnostic Imaging; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Prognosis; Puberty, Precocious | 2006 |
Clinical applications of LHRH and its analogues.
Topics: Adolescent; Adult; Animals; Buserelin; Climacteric; Contraception; Corpus Luteum; Cryptorchidism; Female; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Ovulation; Pituitary Gland; Prostatic Neoplasms; Puberty, Delayed; Puberty, Precocious; Rats; Testis | 1983 |
[Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
Topics: Age Determination by Skeleton; Body Height; Buserelin; Child; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Luteinizing Hormone; Multicenter Studies as Topic; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
Topics: Adult; Age Determination by Skeleton; Age Factors; Body Height; Buserelin; Child; Clinical Trials as Topic; Female; Gonadotropin-Releasing Hormone; Humans; Male; Nafarelin; Prognosis; Puberty, Precocious; Triptorelin Pamoate | 1993 |
[Treatment with the LH-RH agonist (Zoladex depot) in patients with puberty praecox].
Topics: Buserelin; Delayed-Action Preparations; Goserelin; Humans; Puberty, Precocious | 1990 |
Clinical applications of LHRH analogues.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Leiomyoma; Male; Ovulation; Ovulation Induction; Premenstrual Syndrome; Prostatic Neoplasms; Puberty, Precocious; Uterine Neoplasms; Uterus | 1987 |
9 trial(s) available for buserelin and Familial Precocious Puberty
Article | Year |
---|---|
Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
Topics: Adoption; Body Height; Buserelin; Child; Developing Countries; Female; Growth Hormone; Humans; Puberty; Puberty, Precocious | 2004 |
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrog
Topics: Adolescent; Age Factors; Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Luteolytic Agents; Puberty; Puberty, Precocious; Triptorelin Pamoate | 1995 |
Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments.
Topics: Administration, Intranasal; Body Height; Buserelin; Child; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Puberty, Precocious; Triptorelin Pamoate | 1994 |
Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray.
Topics: Administration, Intranasal; Body Height; Buserelin; Child; Child, Preschool; Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Puberty, Precocious | 1994 |
Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (buserelin).
Topics: Administration, Intranasal; Body Height; Buserelin; Child; Female; Humans; Prognosis; Puberty, Precocious | 1994 |
Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Topics: Adolescent; Body Height; Bone Density; Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Puberty, Precocious; Regression Analysis; Triptorelin Pamoate | 1998 |
Suppression of puberty in girls with short-acting intranasal versus subcutaneous depot GnRH agonist.
Topics: Administration, Intranasal; Buserelin; Child; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Patient Compliance; Puberty, Precocious | 2002 |
Luteinizing hormone-releasing hormone analogue (Buserelin) treatment for central precocious puberty: a multi-centre trial.
Topics: Administration, Inhalation; Age Determination by Skeleton; Body Height; Buserelin; Child; Child, Preschool; Female; Humans; Injections, Subcutaneous; Male; Multicenter Studies as Topic; Puberty, Precocious | 1990 |
Urinary excretion of [D-Ser(t-Bu)6,Des-Gly10]GnRH ethylamide (buserelin) during therapy of central precocious puberty: a multicentre study.
Topics: Administration, Intranasal; Buserelin; Child; Drug Resistance; Female; Humans; Injections, Subcutaneous; Male; Multicenter Studies as Topic; Puberty, Precocious | 1990 |
45 other study(ies) available for buserelin and Familial Precocious Puberty
Article | Year |
---|---|
Buserelin Inhibits the Immunosuppressive Activity of Regulatory T Cells through the Protein Kinase A Signaling in a Central Precocious Puberty Model.
Topics: Animals; Buserelin; Cyclic AMP-Dependent Protein Kinases; Forkhead Transcription Factors; Humans; Nuclear Receptor Subfamily 1, Group F, Member 3; Puberty, Precocious; Rats; Signal Transduction; T-Lymphocytes, Regulatory | 2022 |
Can bone age determination provide criteria for growth hormone treatment in adopted girls with early puberty?
Topics: Adoption; Age Factors; Body Height; Bone and Bones; Bone Development; Buserelin; Child; Drug Therapy, Combination; Female; Growth Hormone; Humans; Patient Selection; Prognosis; Puberty, Precocious; Treatment Outcome | 2006 |
Analogues of gonadotrophin releasing hormone.
Topics: Animals; Breast Neoplasms; Buserelin; Child; Dogs; Female; Humans; Male; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Puberty, Precocious | 1984 |
Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone.
Topics: Administration, Intranasal; Androgens; Buserelin; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infant; Injections, Subcutaneous; Luteinizing Hormone; Male; Puberty, Precocious | 1984 |
Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue.
Topics: Buserelin; Child; Child, Preschool; Depression, Chemical; Female; Follicle Stimulating Hormone; Humans; Infant; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Puberty, Precocious; Sex Factors | 1984 |
Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Belgian Study Group for Pediatric Endocrinology.
Topics: Administration, Intranasal; Body Height; Bone Development; Buserelin; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Precocious; Triptorelin Pamoate | 1994 |
Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
Topics: Body Height; Bone Development; Buserelin; Child; Estradiol; Female; Gonadotropin-Releasing Hormone; Growth; Humans; Luteinizing Hormone; Ovary; Pituitary Gland; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Precocious puberty due to a lipid-cell tumour of the ovary.
Topics: Buserelin; Child, Preschool; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Neoplasms; Puberty, Precocious; Recurrence | 1993 |
Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
Topics: Adolescent; Analysis of Variance; Androgen Antagonists; Buserelin; Child; Cyproterone Acetate; Endopeptidases; Gonadotropin-Releasing Hormone; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Puberty; Puberty, Precocious; Regression Analysis | 1996 |
Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment.
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Buserelin; Child; Cyproterone Acetate; Female; Gonadotropin-Releasing Hormone; Humans; Male; Prostate-Specific Antigen; Puberty, Precocious; Radioimmunoassay; Sex Hormone-Binding Globulin; Testis; Testosterone | 1997 |
Long-term outcome of male-limited gonadotropin-independent precocious puberty.
Topics: Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follicle Stimulating Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Receptors, LH; Testosterone | 1997 |
Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Topics: Administration, Inhalation; Administration, Oral; Body Height; Buserelin; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Growth Disorders; Hamartoma; Humans; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Progesterone Congeners; Puberty, Precocious; Treatment Outcome; Twins, Monozygotic | 1999 |
Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
Topics: Adolescent; Age Factors; Analysis of Variance; Body Composition; Body Mass Index; Buserelin; Carrier Proteins; Case-Control Studies; Child; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Linear Models; Male; Puberty, Precocious; Sex Factors; Testosterone | 2000 |
Gonadotropin-releasing hormone analogues in the management of precocious puberty.
Topics: Body Height; Buserelin; Child; Female; Gonadotropin-Releasing Hormone; Humans; Male; Menstrual Cycle; Ovulation; Puberty, Precocious; Triptorelin Pamoate | 2000 |
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
Topics: Adolescent; Body Height; Bone Density; Buserelin; Dihydrotestosterone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Puberty, Precocious; Sperm Count; Sperm Motility; Testis; Testosterone; Triptorelin Pamoate | 2000 |
End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.
Topics: Aerosols; Body Height; Bone Density; Bone Development; Brain Diseases; Buserelin; Child; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Puberty, Precocious; Retrospective Studies; Treatment Outcome; Triptorelin Pamoate | 2000 |
Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
Topics: Buserelin; Child; Child, Preschool; Cyproterone Acetate; Female; Fertility; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Inhibins; Prostatic Secretory Proteins; Puberty, Precocious; Triptorelin Pamoate | 2000 |
Decreased bone mineral density during GnRH analog therapy and polymorphism of estrogen receptor gene in precocious puberty.
Topics: Bone Density; Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Puberty, Precocious; Receptors, Estrogen | 1999 |
[Etiology and therapy of virilism and precocious puberty].
Topics: Adrenal Hyperplasia, Congenital; Buserelin; Child; Cyproterone; Cyproterone Acetate; Dexamethasone; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty, Precocious; Virilism | 1992 |
Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development.
Topics: Biological Availability; Breast; Buserelin; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infant; Luteinizing Hormone; Puberty, Precocious; Sexual Maturation | 1990 |
Thelarche variant: a new syndrome of precocious sexual maturation?
Topics: Body Height; Bone Development; Breast; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Hair; Humans; Infant; Luteinizing Hormone; Pelvis; Pituitary Hormone-Releasing Hormones; Puberty, Precocious; Pubic Symphysis; Sexual Maturation; Syndrome; Ultrasonography | 1990 |
[True precocious puberty in girl. Therapy with LHRH analogs].
Topics: Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Puberty, Precocious; Triptorelin Pamoate | 1990 |
Treatment of central precocious puberty with LH-RHa (buserelin): long term effect on growth, bone maturation and predicted height.
Topics: Body Height; Bone and Bones; Buserelin; Child; Child, Preschool; Female; Growth; Humans; Male; Puberty, Precocious | 1989 |
Treatment of precocious puberty using an intranasal luteinizing hormone-releasing hormone analogue: Buserelin.
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Gonadal Steroid Hormones; Hong Kong; Humans; Infant; Long-Term Care; Male; Puberty, Precocious; Sexual Maturation | 1989 |
[Subcutaneous and intranasal use of a LH-RH analog in the treatment of girls with central precocious puberty].
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Humans; Infant; Injections, Subcutaneous; Luteinizing Hormone; Medroxyprogesterone; Puberty, Precocious; Sexual Maturation | 1989 |
[Pseudo- and central precocious puberty due to adrenogenital syndrome].
Topics: Adrenal Hyperplasia, Congenital; Buserelin; Child; Child, Preschool; Cyproterone; Cyproterone Acetate; Disorders of Sex Development; Female; Genitalia; Humans; Hydrocortisone; Male; Puberty, Precocious | 1986 |
Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment.
Topics: Aging; Body Height; Bone Development; Buserelin; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Puberty, Precocious; Testosterone; Vagina | 1987 |
Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
Topics: Buserelin; Child, Preschool; Cyproterone; Cyproterone Acetate; Estradiol; Estrogens; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Luteinizing Hormone; Ovary; Prolactin; Puberty, Precocious | 1988 |
Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Buserelin; Child Behavior; Child, Preschool; Drug Resistance; Follicle Stimulating Hormone; Growth; Humans; Hydroxyprogesterones; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Testosterone | 1985 |
Pharmacokinetic characteristics of the gonadotropin-releasing hormone analog D-Ser(TBU)-6EA-10luteinizing hormone-releasing hormone (buserelin) after subcutaneous and intranasal administration in children with central precocious puberty.
Topics: Administration, Intranasal; Antibody Formation; Buserelin; Child; Humans; Injections, Subcutaneous; Kinetics; Puberty, Precocious; Radioimmunoassay | 1986 |
[Management of true precocious puberty with a delayed-action Gn-RH analog].
Topics: Buserelin; Child; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Humans; Male; Puberty, Precocious; Testosterone | 1986 |
[Role of pelvic ultrasonography in the diagnosis, therapeutic indications and surveillance of central precocious puberty].
Topics: Buserelin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Ovarian Cysts; Ovarian Neoplasms; Pelvis; Puberty, Precocious; Ultrasonography | 1986 |
[Treatment of central precocious puberty with an LHRH analog. Effect on growth and bone maturation after 2 years of treatment].
Topics: Body Height; Bone Development; Buserelin; Child; Child, Preschool; Female; Follow-Up Studies; Growth; Humans; Injections, Subcutaneous; Male; Puberty, Precocious; Time Factors | 1987 |
The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty.
Topics: Bone Development; Buserelin; Child; Child, Preschool; Female; Gonadal Steroid Hormones; Growth; Humans; Male; Puberty, Precocious | 1987 |
Pharmacodynamics of [D-Ser (t-Bu)6,Des-Gly10]GnRH ethylamide (Buserelin) in 6 normal volunteers. Its usefulness to monitor treatment of central precocious puberty.
Topics: Administration, Intranasal; Adolescent; Adult; Buserelin; Child; Child, Preschool; Female; Humans; Injections, Subcutaneous; Male; Puberty, Precocious; Radioimmunoassay | 1987 |
[Pathologic hemorrhages in childhood].
Topics: Buserelin; Child; Female; Humans; Puberty, Precocious; Uterine Hemorrhage | 1987 |
Evaluation and significance of the degree of pituitary-gonadal inhibition during intranasal administration of buserelin.
Topics: Administration, Intranasal; Adolescent; Bone Development; Breast; Buserelin; Child; Child, Preschool; Dose-Response Relationship, Drug; Estradiol; Female; Follicle Stimulating Hormone; Gonads; Growth Disorders; Humans; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Precocious | 1987 |
Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).
Topics: Administration, Intranasal; Body Height; Bone Development; Buserelin; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Puberty, Precocious; Testosterone | 1987 |
Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins.
Topics: Administration, Intranasal; Atrophy; Bone Development; Buserelin; Child; Child, Preschool; Female; Gonadotropins, Pituitary; Humans; Infant; Male; Puberty, Precocious; Radioimmunoassay; Testis | 1988 |
LH-RH agonistic analog (buserelin) treatment of precocious puberty: collaborative study in Japan.
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Humans; Infant; Injections, Subcutaneous; Luteinizing Hormone; Male; Puberty, Precocious | 1988 |
[Precocious puberty: results of treatment with the LH-RH agonist buserelin].
Topics: Body Height; Buserelin; Child; Child, Preschool; Female; Humans; Puberty, Precocious | 1988 |
Evaluation of buserelin (LHRHa) in the management of precocious puberty.
Topics: Buserelin; Child; Child, Preschool; Female; Humans; Male; Puberty, Precocious | 1988 |
The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Polycystic Ovary Syndrome; Puberty, Precocious | 1985 |
Reversible inhibition of central precocious puberty with a long acting GnRH analogue.
Topics: Buserelin; Child; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pituitary Hormone-Releasing Hormones; Puberty, Precocious | 1985 |
Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty.
Topics: Buserelin; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Growth; Humans; Injections, Subcutaneous; Luteinizing Hormone; Puberty, Precocious; Time Factors; Vagina | 1985 |